Clarkston Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Clarkston Capital Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$233K	–	200
2022 Q1	$233K	Hold	2,000	–	–	﹤0.01%	159
2021 Q4	$301K	Buy	2,000 +198	+11%	+$26.7K	0.01%	135
2021 Q3	$215K	Buy	+1,802	New	+$199K	﹤0.01%	140
2020 Q4	–	Sell	-2,000	Closed	-$227K	–	137
2020 Q3	$227K	Buy	+2,000	New	+$210K	0.01%	99

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Clarkston Capital Partners's TNDM Position: Q2 2022 in Review

Clarkston Capital Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,000 shares — an estimated $233K sold.

Clarkston Capital Partners first reported a position in TNDM in Q3 2020 and held it in 4 quarters. The position peaked at $301K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Clarkston Capital Partners reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Clarkston Capital Partners sold 2,000 Tandem Diabetes Care shares in Q2 2022, an estimated $233K.
Clarkston Capital Partners first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 4 quarters.
Clarkston Capital Partners's Tandem Diabetes Care position peaked at $301K in Q4 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Clarkston Capital Partners's 13F filing for Q2 2022, filed 10 Aug 2022.